A series of class actions over the exclusion of coverage for GLP-1 weight loss drugs is testing several legal strategies against how health insurance plans decide which drugs to cover and why
The composition of claim 1 comprising 120 mg of 9-[2-[[bis[(pivaloyloxy) methyl]phosphono]methoxy]ethyl]adenine, 12-24 mg magnesium carbonate, 124-162 mg lactose monohydrate or anhydrous lactose, 60 mg microcrystalline cellulose, 20 mg pregelatinized starch, 24 mg of croscarmellose sodium, 0-24 mg talc and 2-4 mg magnesium stearate The composition of claim 1 comprising 4-8 % w/w of 9-[2-[[bis[(pivaloyloxy) mefhyl]phosphono]methoxy]ethyl]adenine, 1-6 % w/w magnesium carbonate, 24-51 % w/w L-carnitine-L-tartrate, 20-36 % w/w microcrystalline cellulose, 5 % w/w pregelatinized starch, 4 % w/w croscarmellose sodium, and (1) 1% w/w sodium stearyl fumarate or (2) 2 % w/w talc and 1 % w/w type I hydrogenated vegetable oil
Peptides are naturally occurring in the body and designed to mimic or support biological functions
Centrifuge for 10 min (12000 rpm, 4C), take 200 L of the lower chloroform layer into a new centrifuge tube
Its unacceptable
Tirzepatide was approved by the U.S